Karthik Viswanathan

Karthik Viswanathan

Company: Visterra, Inc.

Job title: Executive Director, Research


Precision Antibody-Based Therapeutics for Complement Regulation 3:00 pm

Targeting critical components of the complement pathway can impact diseases that are initiated or exacerbated by complement dysregulation Antibody based therapeutics can be used to precisely target and potently inhibit complement activation Visterra has developed novel antibodies for targeting complement activationRead more

day: Track A - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.